The Society for Cardiovascular Angiography and Interventions (SCAI) provides this written statement to the U.S. Food and Drug Administration's (FDA or The Agency) Circulatory System Devices Panel (The Panel) regarding the available published safety and effectiveness data for transcatheter Atrial Septal Defect (ASD)